Hepatitis C / Projects

3rd Health Programme (2014-2020)
EPHA Operating Grant Proposal 2016 SGA [EPHA SGA 2016]
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four o...
The Annual Work Programme for 2016 of EPHA is drawn from the multiannual work programme 2015-2017 and builds on successes to date. EPHA’s activities in 2016 will continue to contribute to all four objectives of the Third Health Programme. EPHA has formally reviewed our Strategic Plan 2011-2015. We undertook a thorough consultation process involving Board members, Staff and the EPHA membership, and an analysis of EPHA’s operating environment, strengths and weaknesses. The EPHA membership formally approved the new Strategic Plan 2016-2020 at the Annual General Assembly on 4th September 2015. The Work Programme for 2016 reflects the revised strategy to define a clearer selection of priorities. This approach will enable EPHA to manage activities more effectively, encourage closer cooperation between members and across themes, and better monitor and evaluate our impact.EPHA’s overarching strategic objective remains: “To promote good health and wellbeing, to reduce disease and health inequalities in European policies and programmes”. Priorities selected are as follows:Under Aims 1 and 2 of the 3rdHP and EPHA Strategic Objective “Securing a Governance for Health Approach in Key EU Policies” (HiAP):- Agriculture and Food Policy including Alcohol, Tobacco and NCDs- EU Semester for Health- Healthy Trade Policy- Public Health and Research in the EU BudgetUnder Aims 3 and 4 of the 3rdHP and EPHA Strategic Objective “Strengthen EU Policies to Reduce Health Inequalities and Ensure Universal Access to Sustainable, Inclusive Health Systems”:- Universal and Fair Access to Medicines- Action on Antimicrobial Resistance- Inclusive E- and M-Health- HSPAEach of these areas has operational objectives, milestones, deliverables and impact indicators. The Work Programme 2016 also highlights organisational development objectives, particularly on cooperation with academia, communications and financial sustainability, which are priorities for 2016.
Start date: 01/01/2016 - End date: 31/12/2016
Keywords : [ Amr ] [ Anthrax ] [ Anthrax ] [ Blood ] [ Botulism ] [ Breast ] [ Brucellosis ] [ Campylobacteriosis ] [ Cancer ] [ Cardiovascular Diseases ] [ Cervical ] [ Chlamydia ] [ Cholera ] [ Chronic Diseases ] [ Chronic Diseases ] [ Chronic kidney diseases ] [ Chronic pulmonary diseases ] [ Colorectal ] [ Communicable Diseases ] [ Communicable Diseases ] [ Cryptosporidiosis ] [ Dengue fever ] [ Diabetes ] [ Diphtheria ] [ Diseases of zoonotic and environmental origin and vector borne ] [ E ] [ E/M-Health ] [ Echinococcosis ] [ Economic Policy ] [ Emergent pathogens ] [ Epilepsy ] [ Food and waterborne diseases ] [ Giardisasis ] [ Gonorrhea ] [ HIV, STIs & Blood borne infections ] [ Health Research ] [ Healthcare-associated infections ] [ Hepatitis A ] [ Hepatitis B ] [ Hepatitis C ] [ Hiap ] [ Hiv/Aids ] [ Hpv ] [ Hspa ] [ Hspa. ] [ Influenza ] [ Invasive Haemophilus influenzae disease ] [ Invasive pneumococcal disease ] [ Ischaemic heart disease ] [ Legionnaire's diseaese ] [ Leptospirosis ] [ Leptospirosis ] [ Listeriosis ] [ Lung ] [ M-Health ] [ Malaria ] [ Measles ] [ Menongoccal disease ] [ Multiple sclerosis ] [ Mumps ] [ Musculo skeletal conditions ] [ Ncds ] [ Neurological diseases and disorders ] [ Other specific diseases ] [ Parkinson's disease ] [ Participation ] [ Plague ] [ Polio ] [ Prevention ] [ Prevention ] [ Promotion ] [ Protection ] [ Public Health ] [ Qfever ] [ Rabies ] [ Respiratory tract infections ] [ Rubella ] [ SARS ] [ Salmonellosis ] [ Shigellosis ] [ Shigellosis ] [ Smallpox ] [ Stomach ] [ Stroke ] [ Syphilis ] [ Tetanus ] [ Toxoplasmosis ] [ Trade ] [ Trichinellosis ] [ Tuberculosis ] [ Tularaemia ] [ Tularemia ] [ Type I ] [ Typhoid fever ] [ Universal Access ] [ VTEC ] [ Vaccine-preventable diseases ] [ Variant Creutzfeld-Jakob disease ] [ Viral Haemorrhagic fevers ] [ West Nile fever ] [ Yellow fever ] [ Yersiniosis ] [ campylobacteriosis ] [ pertussis ] [ prostate ] [ salmonellosis ] [ skin ] [ type II ]

Call: Health Programme Adhoc Call for invited (named) beneficiaries
Topic: Hepatitis C
Second Programme of Community action in the Field of Health 2008-2013
HBV-HCV-HIV: THREE DIFFERENT AND SERIOUS THREATS FOR EUROPEAN YOUNG PEOPLE. A NETWORK TO STUDY AND TO FACE THESE CHALLENGES IN EU [H-CUBE]
To identify and disseminate good practices, contents and tools about HBV, HCV and HIV training programmes and prevention campaigns aiming to help Public Administrations and NGOs in Italy, Romania, Gre...
To identify and disseminate good practices, contents and tools about HBV, HCV and HIV training programmes and prevention campaigns aiming to help Public Administrations and NGOs in Italy, Romania, Greece, Slovenia, Poland, Czech Republic, Bulgaria, Hungary, Cyprus, Malta and Lithuania.
Start date: 01/05/2009 - End date: 01/11/2011

Call: Promote Health (Hp-2008)
Topic: Hepatitis C
First Programme of Community action in the field of public health (2003-2008)
Expanding Network for Coordinated and Comprehensive Actions on HIV/AIDS Prevention among IDUs and Bridging Population [ENCAP]
The ENCAP project overall objective is to prevent the transmission of HIV and other infections in high-risk group and bridging population in project area. Whereas project purpose is to develop and str...
The ENCAP project overall objective is to prevent the transmission of HIV and other infections in high-risk group and bridging population in project area. Whereas project purpose is to develop and strengthen specially targeted network of LTCs for HIV/AIDS prevention among IDUs and bridging population in the project area by addressing issues of awareness on HIV and other infections and decreasing risk behaviour of target groups.

The specific project objective is to strengthen and develop the specially targeted networking for HIV/AIDS prevention among IDUs and bringing population in the Project Area.

Start date: 01/07/2006 - End date: 01/07/2009

Call: Health Determinants (Hd 2005)
Topic: Hepatitis C
Second Programme of Community action in the Field of Health 2008-2013
Screening for Hepatitis B and C among migrants in the European Union [EU-HEP-SCREEN]
Chronic viral hepatitis B and C is a major health problem in many European countries. Migrants from endemic areas in particular, are the most affected and underserved population groups. The general ob...
Chronic viral hepatitis B and C is a major health problem in many European countries. Migrants from endemic areas in particular, are the most affected and underserved population groups. The general objective of this project is to assess, describe and communicate to public health professionals the tools and conditions necessary for implementing successful screening programmes for hepatitis B and C among migrants in the European Union.


Start date: 01/10/2011 - End date: 01/11/2014

Call: Improve Citizen''S Health Security (Hs-2010)
Topic: Hepatitis C
3rd Health Programme (2014-2020)
Correlation Network on Harm Reduction and Social Inclusion [CN]
The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve th...
The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve the access to and the quality of harm reduction services for People Who Use Drugs (PWUD), including other related vulnerable and marginalised people and to enhance policies and practices that increase social inclusion.

This is achieved by the following strategic objectives
- Strengthen the network and the collaboration with its members and partners through an adequate and solid organisational network structure
- Monitor developments and collect information and evidence in the field of drug use and harm reduction, by involving the expertise of civil society organisations
- Strengthen capacities of the various players in the field of drug use and harm reduction and facilitate exchange between network members and partners
- Advocate for full coverage of harm reduction programmes in Europe, addressing both health and social aspects.

All CN activities will pay specific attention to Hepatitis C, new drug trends and drug patterns and overdose prevention. Relevant CN outputs include : Sustainable network, Annual Monitoring Reports, Online knowledge and training hub, European Harm Reduction Conferences (2018/20), policy recommendations.

CN contributes to the Third Health Programme (THP) by promoting health (in particular harm reduction), prevent diseases (in particular drug-related diseases and infectious diseases such as HCV and HIV/AIDS), and foster supportive environments for healthy lifestyles (e.g. by reducing barriers to access health and social services).

CN contributes as well to the following THP priorities:
1.2. Drugs-related health damage, including information and prevention
1.3. HIV/AIDS, tuberculosis and hepatitis
2.2. Capacity-building against health threats in Member States, including, where appropriate, cooperation with
neighbouring countries



Start date: 30/01/2018 - End date: 29/01/2022

Call: Operating grants 2018-2021
Topic: Hepatitis C